Kymera Therapeutics, Inc.

NASDAQ:KYMR

Biotechnology

Healthcare
$119.39 +1.67%

+$1.50 today

Market cap
$10.19B
Beta
2.03
P/E (TTM)
-28.3
EPS (TTM)
-$3.23
52W Low $36.65High $103.00

Volume 0.72M

Average 0.58M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.74B

FY 2025 · Annual

+78.2% YoY

Liabilities

$163.15M

FY 2025 · Annual

+14.6% YoY

Equity

$1.58B

FY 2025 · Annual

+89.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents47.98M68.4M109.97M120.26M357.01M
Short-term Investments394.44M338.77M264.92M368.49M491.27M
Net Receivables135K2.54M18.76M947K0
Inventory00000
Other Current Assets09.71M11.67M20.58M22.94M
Total Current Assets451.27M419.42M405.32M510.27M871.21M
Property, Plant & Equipment (Net)21.31M22.24M101.08M97.86M85.53M
Goodwill00000
Intangible Assets00000
Long-term Investments125.19M152.33M61.43M362.16M776.96M
Tax Assets00000
Other Non-current Assets8.14M9.15M7.93M7.74M9.11M
Total Non-current Assets154.63M183.72M170.44M467.77M871.6M
Total Assets605.91M603.13M575.76M978.04M1.74B
Account Payables4.01M4.34M7.08M5.99M4.01M
Short-term Debt000013.76M
Tax Payables00000
Deferred Revenue61.74M35.26M37.88M13.58M22.93M
Other Current Liabilities228K303K23.16M223K24.21M
Total Current Liabilities92.54M71.34M85.69M67.77M83.21M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)39.3M28M16.77M011.44M
Other Non-current Liabilities66K248K000
Total Non-current Liabilities53.73M41.64M95.1M74.65M79.94M
Total Liabilities146.27M112.98M180.79M142.42M163.15M
Common Stock5K6K6K7K8K
Retained Earnings(228.98M)(383.79M)(530.75M)(754.61M)(1.07B)
Accumulated OCI(660K)(4.95M)(552K)(1.49M)1.8M
Other Stockholders Equity00000
Minority Interest00000
Total Equity459.64M490.15M394.97M835.62M1.58B
Total Debt17.96M17.34M84.67M87.76M82.25M
Net Debt(30.01M)(51.06M)(25.29M)(32.5M)(274.76M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$124.5M
Short-term Investments$566.5M
Receivables$20.0M
Inventory-$5.8M
Other Current$32.1M
Total Current Assets$737.3M
PP&E (Net)$81.1M
Long-term Investments$813.9M
Other Non-current$7.0M
Total Non-current Assets$902.0M
Total Assets$1.6B

Analysis

Selected assets total $1.6B for Latest. The largest visible component is Long-term Investments at $813.9M, about 49.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 29, 2026
10-QQuarterly reportOct 29, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
4Statement of changes in beneficial ownershipOct 1, 2026
SC 13G/ASC 13G/A filingSep 8, 2026

How much cash does KYMR have?

Kymera Therapeutics, Inc. (KYMR) reported $357.01M in cash and equivalents in fiscal 2025.

How much debt does KYMR carry?

Kymera Therapeutics, Inc. (KYMR) reported $82.25M of total debt, with net debt of -$274.76M.